KMT2A and acute lymphoblastic leukemia: Specifically, expression analysis revealed increased NLRP3 expression in pediatric BCP‐ALL and MLL‐ALL PDX samples compared to the other five leukemia subtypes analyzed, with T‐ALL exhibiting the lowest expression level.